Treace Medical Concepts (TMCI) Stock Price
Treace Medical Concepts Price
Revenue has compounded at 32.4% per year over the past 6 years to 207.37 M USD. Treace Medical Concepts's net margin stands at -28.5%, down from -22.7% several years earlier. Analysts set a median price target of 6.50 USD, implying 61.3% above the current price. Of 10 analysts, 1 rate the stock a buy — an overall Hold consensus.
Treace Medical Concepts stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Treace Medical Concepts business model & stock analysis
Frequently asked questions about Treace Medical Concepts
Treace Medical Concepts Inc operates with a business model focused on orthopedic medical devices. As a company, they specialize in developing and commercializing innovations for foot and ankle surgical procedures. Treace Medical Concepts Inc aims to provide advanced treatment solutions through their portfolio of products. With a focus on improving patient outcomes and surgeon experience, the company strives to address the unmet needs of the foot and ankle surgical market. Through their dedication to developing specialized medical devices, Treace Medical Concepts Inc continues to contribute to the advancement of orthopedic care.
Treace Medical Concepts Inc is primarily active in the healthcare and medical industry.
The main competitors of Treace Medical Concepts Inc in the market include renowned medical device companies such as Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings Inc.
Treace Medical Concepts Inc is a renowned medical device company specializing in foot and ankle surgical procedures. Established in 2014, the company has rapidly gained recognition for its innovative products and surgical techniques, offering advanced solutions to address various foot and ankle conditions. Treace Medical Concepts Inc has revolutionized treatment with its flagship product, Lapiplasty® 3D Bunion Correction™ System, which provides a more effective and lasting solution compared to traditional bunion surgeries. With a commitment to improving patient outcomes and advancing foot and ankle care, Treace Medical Concepts Inc continues to lead the way in the field of orthopedic medicine.
Treace Medical Concepts Inc. has achieved noteworthy milestones since its inception. With a strong focus on surgical solutions for foot and ankle conditions, the company has been successful in revolutionizing the orthopedic industry. Treace Medical Concepts Inc.'s most significant milestone came with the development and introduction of the patented Lapiplasty® 3D Bunion Correction™ System. This innovative system provides a reliable and reproducible surgical solution for bunion deformities, addressing the root cause and providing lasting relief to patients. The company's commitment to innovation and advancement in foot and ankle surgery has positioned Treace Medical Concepts Inc. as a leader in the industry, delivering improved patient outcomes and transforming the standard of care.
Treace Medical Concepts Inc is primarily present in the United States.
Treace Medical Concepts Inc is a renowned medical company that upholds strong values and a robust corporate philosophy. The company is committed to delivering innovative and comprehensive solutions for foot and ankle healthcare. With a steadfast focus on patient-centered care, Treace Medical Concepts Inc strives to improve the quality of life for individuals suffering from various foot conditions. Their dedication to research, development, and exceptional quality standards enables them to provide effective treatments and surgical solutions. With a focus on continuous improvement and excellence, Treace Medical Concepts Inc sets the benchmark for superior foot and ankle healthcare in the industry.
Analysts currently set an average price target of 8.60 USD for the Treace Medical Concepts stock (median: 6.50 USD), implying +113.4 % versus the latest price. The consensus is based on 10 analyst ratings.
10 analysts currently rate the Treace Medical Concepts stock: 1 recommend buying, 5 holding and 4 selling. For 2026, analysts expect Treace Medical Concepts to generate revenue of 207.56 M USD and earnings per share of -0.85 USD.
Converted at the current exchange rate, the Treace Medical Concepts share trades at 3.60 EUR (4.03 USD).
The Treace Medical Concepts share (TMCI) is listed on 1 stock exchanges, including: NASDAQ (TMCI).
Treace Medical Concepts Inc is a company specializing in the development, manufacturing, and sale of innovative medical devices for orthopedics and foot surgery. The company is headquartered in Ponte Vedra Beach, Florida and was founded in 2014 by an experienced team of physicians and entrepreneurs. The company has various departments, including innovation, sales, information, and marketing. The innovation department conducts research and development projects to develop groundbreaking technologies for use in the orthopedic and foot surgery industry. One of the company's most well-known product lines is the Lapiplasty® procedures, used for correcting hallux valgus. The unique Lapiplasty® procedure not only corrects the alignment of the big toe but also correctly aligns the three important joint angles. This leads to better long-term stability and prevention of relapses. The Lapiplasty® system is the only system that allows for complete three-dimensional correction and enables a quick return to wearing regular shoes. The company also offers a range of other products, including the Fastgraft® Meniscal Viable Repair System, which allows for minimally invasive arthroscopic repair of the meniscus, and the Zip® system, a device for minimally invasive pain reduction in foot procedures. The company's sales department works closely with customers and facilities to ensure that the products can be used quickly and effectively. The information department provides training materials and educational formats, ensuring smooth integration and handling of the products. The company's marketing department is responsible for presenting the company and its products and positioning itself in the market. This involves attending various industry events such as medical technology fairs and conferences to promote the company's products and maintain contacts with potential customers. Treace Medical Concepts Inc's business model is based on close collaboration with the users of its products. Feedback from physicians, nurses, and patients is incorporated into the ongoing development of the products and business strategy. The company continuously strives to advance and enable groundbreaking innovations in the field of orthopedics and foot surgery and improve surgical procedures and methods. In summary, Treace Medical Concepts Inc is an innovative company in the medical technology industry specializing in the development of new technologies to improve orthopedics and foot surgery. Collaboration with users, the development of training programs, effective sales management, and product marketing are key pillars of the business strategy.
The expected revenue of Treace Medical Concepts is 207.56 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Treace Medical Concepts is -54.16 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Treace Medical Concepts is currently -4.75. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Treace Medical Concepts stock.
The price-to-sales ratio (P/S) of Treace Medical Concepts is currently 1.24. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Treace Medical Concepts stock.
The Eulerpool Quality Score for Treace Medical Concepts is 4/10.
The ISIN of Treace Medical Concepts is US89455T1097. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Treace Medical Concepts is TMCI. The ticker symbol is used to trade Treace Medical Concepts shares on the stock exchange.
Treace Medical Concepts stock
Treace Medical Concepts Peer Group
Treace Medical Concepts Ticker
Treace Medical Concepts FIGI
All fundamentals and in-depth analysis of Treace Medical Concepts
Our stock analysis for Treace Medical Concepts stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Treace Medical Concepts. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.